408 related articles for article (PubMed ID: 25869208)
41. FOXM1 evokes 5-fluorouracil resistance in colorectal cancer depending on ABCC10.
Xie T; Geng J; Wang Y; Wang L; Huang M; Chen J; Zhang K; Xue L; Liu X; Mao X; Chen Y; Wang Q; Dai T; Ren L; Yu H; Wang R; Chen L; Chen C; Chu X
Oncotarget; 2017 Jan; 8(5):8574-8589. PubMed ID: 28051999
[TBL] [Abstract][Full Text] [Related]
42. Marine lipopeptide Iturin A inhibits Akt mediated GSK3β and FoxO3a signaling and triggers apoptosis in breast cancer.
Dey G; Bharti R; Dhanarajan G; Das S; Dey KK; Kumar BN; Sen R; Mandal M
Sci Rep; 2015 May; 5():10316. PubMed ID: 25974307
[TBL] [Abstract][Full Text] [Related]
43. Positive feedback loop of IL-1β/Akt/RARα/Akt signaling mediates oncogenic property of RARα in gastric carcinoma.
Ren HY; Liu F; Huang GL; Liu Y; Shen JX; Zhou P; Liu WM; Shen DY
Oncotarget; 2017 Jan; 8(4):6718-6729. PubMed ID: 28035062
[TBL] [Abstract][Full Text] [Related]
44. Akt-FOXO3a signaling axis dysregulation in human oral squamous cell carcinoma and potent efficacy of FOXO3a-targeted gene therapy.
Fang L; Wang H; Zhou L; Yu D
Oral Oncol; 2011 Jan; 47(1):16-21. PubMed ID: 21109483
[TBL] [Abstract][Full Text] [Related]
45. FOXM1-LDHA signaling promoted gastric cancer glycolytic phenotype and progression.
Jiang W; Zhou F; Li N; Li Q; Wang L
Int J Clin Exp Pathol; 2015; 8(6):6756-63. PubMed ID: 26261559
[TBL] [Abstract][Full Text] [Related]
46. IBP-mediated suppression of autophagy promotes growth and metastasis of breast cancer cells via activating mTORC2/Akt/FOXO3a signaling pathway.
Chen S; Han Q; Wang X; Yang M; Zhang Z; Li P; Chen A; Hu C; Li S
Cell Death Dis; 2013 Oct; 4(10):e842. PubMed ID: 24113176
[TBL] [Abstract][Full Text] [Related]
47. miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer.
Tan X; Fu Y; Chen L; Lee W; Lai Y; Rezaei K; Tabbara S; Latham P; Teal CB; Man YG; Siegel RS; Brem RF; Fu SW
Oncotarget; 2016 Jan; 7(1):293-307. PubMed ID: 26588055
[TBL] [Abstract][Full Text] [Related]
48. Activation of AKT pathway by Nrf2/PDGFA feedback loop contributes to HCC progression.
Liu D; Zhang Y; Wei Y; Liu G; Liu Y; Gao Q; Zou L; Zeng W; Zhang N
Oncotarget; 2016 Oct; 7(40):65389-65402. PubMed ID: 27588483
[TBL] [Abstract][Full Text] [Related]
49. AKT/FOXM1/STMN1 signaling pathway activation by SMC1A promotes tumor growth in breast cancer.
Li K; Dai P; Li J; Liu L; Cheng S; Fang Q; Wu B
J Gene Med; 2024 Jan; 26(1):e3661. PubMed ID: 38282144
[TBL] [Abstract][Full Text] [Related]
50. 3,3'-Diindolylmethane potentiates paclitaxel-induced antitumor effects on gastric cancer cells through the Akt/FOXM1 signaling cascade.
Jin H; Park MH; Kim SM
Oncol Rep; 2015 Apr; 33(4):2031-6. PubMed ID: 25633416
[TBL] [Abstract][Full Text] [Related]
51. Knockdown of FLOT1 impairs cell proliferation and tumorigenicity in breast cancer through upregulation of FOXO3a.
Lin C; Wu Z; Lin X; Yu C; Shi T; Zeng Y; Wang X; Li J; Song L
Clin Cancer Res; 2011 May; 17(10):3089-99. PubMed ID: 21447726
[TBL] [Abstract][Full Text] [Related]
52. Effects of the combined blockade of EGFR and ErbB-2 on signal transduction and regulation of cell cycle regulatory proteins in breast cancer cells.
D'Alessio A; De Luca A; Maiello MR; Lamura L; Rachiglio AM; Napolitano M; Gallo M; Normanno N
Breast Cancer Res Treat; 2010 Sep; 123(2):387-96. PubMed ID: 19946741
[TBL] [Abstract][Full Text] [Related]
53. Up-regulation of FOXM1 by E6 oncoprotein through the MZF1/NKX2-1 axis is required for human papillomavirus-associated tumorigenesis.
Chen PM; Cheng YW; Wang YC; Wu TC; Chen CY; Lee H
Neoplasia; 2014 Nov; 16(11):961-71. PubMed ID: 25425970
[TBL] [Abstract][Full Text] [Related]
54. FoxM1B transcriptionally regulates vascular endothelial growth factor expression and promotes the angiogenesis and growth of glioma cells.
Zhang Y; Zhang N; Dai B; Liu M; Sawaya R; Xie K; Huang S
Cancer Res; 2008 Nov; 68(21):8733-42. PubMed ID: 18974115
[TBL] [Abstract][Full Text] [Related]
55. Na+/H+ exchanger regulatory factor 1 inhibits platelet-derived growth factor signaling in breast cancer cells.
Pan Y; Weinman EJ; Dai JL
Breast Cancer Res; 2008; 10(1):R5. PubMed ID: 18190691
[TBL] [Abstract][Full Text] [Related]
56. Activation of AKT/AP1/FoxM1 signaling confers sorafenib resistance to liver cancer cells.
Yan D; Yan X; Dai X; Chen L; Sun L; Li T; He F; Lian J; Cai W
Oncol Rep; 2019 Aug; 42(2):785-796. PubMed ID: 31233189
[TBL] [Abstract][Full Text] [Related]
57. MicroRNA-214 acts as a potential oncogene in breast cancer by targeting the PTEN-PI3K/Akt signaling pathway.
Wang F; Li L; Chen Z; Zhu M; Gu Y
Int J Mol Med; 2016 May; 37(5):1421-8. PubMed ID: 26951965
[TBL] [Abstract][Full Text] [Related]
58. Acylglycerol kinase promotes cell proliferation and tumorigenicity in breast cancer via suppression of the FOXO1 transcription factor.
Wang X; Lin C; Zhao X; Liu A; Zhu J; Li X; Song L
Mol Cancer; 2014 May; 13():106. PubMed ID: 24886245
[TBL] [Abstract][Full Text] [Related]
59. Forkhead Box Transcription Factor (FOXO3a) mediates the cytotoxic effect of vernodalin in vitro and inhibits the breast tumor growth in vivo.
Ananda Sadagopan SK; Mohebali N; Looi CY; Hasanpourghadi M; Pandurangan AK; Arya A; Karimian H; Mustafa MR
J Exp Clin Cancer Res; 2015 Dec; 34():147. PubMed ID: 26643256
[TBL] [Abstract][Full Text] [Related]
60. FOXM1 (Forkhead box M1) in tumorigenesis: overexpression in human cancer, implication in tumorigenesis, oncogenic functions, tumor-suppressive properties, and target of anticancer therapy.
Wierstra I
Adv Cancer Res; 2013; 119():191-419. PubMed ID: 23870513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
